Epoxy Technology Inc. recently announced it has completed ISO 10993 testing on three new products, for a total of 20. The products include:

  • EPO-TEK® 353ND-T, a thioxotropic variation of an established “industry standard” 353ND
  • EPO-TEK OG198-54, a one-component, low-viscosity, electrically and thermally insulating UV epoxy adhesive
  • EPO-TEK 301, a low-viscosity, low-temperature-cured (65°C/1 hour), optically clear, two-component epoxy adhesive

“We at Epoxy Technology Inc. are committed to testing our products to the industry’s most comprehensive ISO 10993 biocompatibility standards,” said Joan Bramer, global sales and marketing director. “These latest positive results for EPO-TEK 353ND-T, OG198-55 and 301, which included an extended, long-term implantation study of 12 weeks for 301 shows our investment in the medical industry.”

For more information, visit www.epotek.com.